Cargando…
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of the Nepal Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252234/ https://www.ncbi.nlm.nih.gov/pubmed/35633247 http://dx.doi.org/10.31729/jnma.7081 |
_version_ | 1784740220964438016 |
---|---|
author | Das, Sunil Kumar Shahi, Arun Panthi, Ram Chandra |
author_facet | Das, Sunil Kumar Shahi, Arun Panthi, Ram Chandra |
author_sort | Das, Sunil Kumar |
collection | PubMed |
description | Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and |3-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis. |
format | Online Article Text |
id | pubmed-9252234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Journal of the Nepal Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-92522342022-07-14 Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report Das, Sunil Kumar Shahi, Arun Panthi, Ram Chandra JNMA J Nepal Med Assoc Case Report Choriocarcinoma is a malignant trophoblastic tumour usually of placental origin. It is characterized by early metastasis to the brain and lungs. With early detection, it has a better prognosis with treatment. We report a case of 18 years female at 26 weeks of gestation in her third pregnancy who had a history of treatment for metastatic gestational trophoblastic neoplasm with chemotherapy and radiotherapy two years back. Therefore, she was managed as a case of recurrent choriocarcinoma with brain metastasis with chemotherapy (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) and was responsive. Her symptoms resolved and |3-human chorionic gonadotropin dropped to normal value (<2.39 mIU/ml) which has shown that timely diagnosis and management can be vital for the successful treatment of brain metastasis. Journal of the Nepal Medical Association 2022-05 2022-05-31 /pmc/articles/PMC9252234/ /pubmed/35633247 http://dx.doi.org/10.31729/jnma.7081 Text en © The Author(s) 2018. https://creativecommons.org/licenses/by/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Das, Sunil Kumar Shahi, Arun Panthi, Ram Chandra Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title | Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title_full | Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title_fullStr | Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title_full_unstemmed | Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title_short | Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report |
title_sort | recurrent metastatic choriocarcinoma responsive to etoposide and cisplatin with etoposide, methotrexate, and dactinomycin: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252234/ https://www.ncbi.nlm.nih.gov/pubmed/35633247 http://dx.doi.org/10.31729/jnma.7081 |
work_keys_str_mv | AT dassunilkumar recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport AT shahiarun recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport AT panthiramchandra recurrentmetastaticchoriocarcinomaresponsivetoetoposideandcisplatinwithetoposidemethotrexateanddactinomycinacasereport |